Mohammad Jahanzeb, MD, FACP, explains what he might do in sequencing therapies as a result of Keynote 189 and Keynote 42 presented at the 2018 Annual Meeting Annual Meeting.
The impact of Keynote 189 & 42 on drug sequencing regimens
Mohammad Jahanzeb, MD, FACP, explains what he might do in sequencing therapies as a result of Keynote 189 and Keynote 42 presented at the 2018 Annual Meeting Annual Meeting.